PERSPECTIVE THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-26.8M | $-26.2M | $-37.5M | $-26.0M | $-21.5M | $-18.2M | $-40.2M | $-15.1M |
| Depreciation & Amortization | $1.1M | $1.1M | $1.0M | $775.0K | $733.0K | $732.0K | $709.0K | $669.0K |
| Depreciation | — | — | — | — | — | — | — | $669.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.0M | $2.6M | $2.3M | $2.2M | $2.4M | $2.1M | $2.1M | $2.0M |
| Net Cash from Operating Activities | $-20.7M | $-31.5M | $-24.7M | $-16.3M | $-20.0M | $-21.6M | $-26.6M | $3.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $14.2M | $6.9M | $5.1M | $2.0M | $1.0M | $4.7M | $14.6M | $29.7M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $15.0M | $-109.6M | $28.5M | $14.0M | $4.3M | $-5.6M | $-138.6M | $-29.7M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $147.0K | $164.4M | $-13.0K | $213.0K | $132.0K | $10.0M | $345.0K | $628.0K |
| Net Change in Cash | $-5.5M | $23.3M | $3.9M | $-2.1M | $-15.6M | $-17.2M | $-164.9M | $-25.7M |
| Free Cash Flow | $-34.8M | $-38.3M | $-29.7M | $-18.3M | $-21.0M | $-26.2M | $-41.2M | $-26.3M |